Particularly in NSCLC, aberrant EGFR signaling is closely associated with malignant biological behaviors, including invasion and metastasis, tumor angiogenesis and chemoresistance [4, 34]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.